| [1] |
HEUBI JE, SETCHELL KD, BOVE KE. Inborn errors of bile acid metabolism[J]. Semin Liver Dis, 2007, 27(3): 282-294. DOI: 10.1055/s-2007-985073. |
| [2] |
SETCHELL KD, SUCHY FJ, WELSH MB, et al. Delta 4-3-oxosteroid 5 beta-reductase deficiency described in identical twins with neonatal hepatitis. A new inborn error in bile acid synthesis[J]. J Clin Invest, 1988, 82(6): 2148-2157. DOI: 10.1172/JCI113837. |
| [3] |
LIU JQ, ZHOU SM, ZHOU JL, et al. A case of congenital bile acid synthesis disorder type 2 and literature review[J]. Chin J Med Genetics, 2018, 35(5): 691-693. DOI: 10.3760/cma.j.issn.1003-9406.2018.05.016. |
| [4] |
SHE LH, LI XF, YE JW, et al. Clinical features and gene variation of congenital bile acid synthesis disorder type 2 in 8 children[J]. J Clin Pediatr, 2020, 38(12): 936-939. DOI: 10.3969/j.issn.1000-3606.2020.12.013. |
| [5] |
CHEN JY, WU JF, KIMURA A, et al. AKR1D1 and CYP7B1 mutations in patients with inborn errors of bile acid metabolism: Possibly underdiagnosed diseases[J]. Pediatr Neonatol, 2020, 61(1): 75-83. DOI: 10.1016/j.pedneo.2019.06.009. |
| [6] |
AL-HUSSAINI AA, SETCHELL K, ALSALEEM B, et al. Bile acid synthesis disorders in arabs: A 10-year screening study[J]. J Pediatr Gastroenterol Nutr, 2017, 65(6): 613-620. DOI: 10.1097/MPG.0000000000001734. |
| [7] |
|
| [8] |
JAHNEL J, ZÖHRER E, FISCHLER B, et al. Attempt to determine the prevalence of two inborn errors of primary bile acid synthesis: Results of a European survey[J]. J Pediatr Gastroenterol Nutr, 2017, 64(6): 864-868. DOI: 10.1097/MPG.0000000000001546. |
| [9] |
HEUBI JE, SETCHELL K, BOVE KE. Inborn errors of bile acid metabolism[J]. Clin Liver Dis, 2018, 22(4): 671-687. DOI: 10.1016/j.cld.2018.06.006. |
| [10] |
|
| [11] |
DAUGHERTY CC, SETCHELL KD, HEUBI JE, et al. Resolution of liver biopsy alterations in three siblings with bile acid treatment of an inborn error of bile acid metabolism (delta 4-3-oxosteroid 5 beta-reductase deficiency)[J]. Hepatology, 1993, 18(5): 1096-1101.
|
| [12] |
DRURY JE, MINDNICH R, PENNING TM. Characterization of disease-related 5beta-reductase (AKR1D1) mutations reveals their potential to cause bile acid deficiency[J]. J Biol Chem, 2010, 285(32): 24529-24537. DOI: 10.1074/jbc.M110.127779. |
| [13] |
LI AQ, DONG Y, XU ZQ, et al. Progressive familial intrahepatic cholestasis type 3: A report of two cases in one pedigree[J]. J Clin Hepatol, 2020, 36(7): 1601-1604. DOI: 10.3969/j.issn.1001-5256.2020.07.032. |
| [14] |
UEKI I, KIMURA A, CHEN HL, et al. SRD5B1 gene analysis needed for the accurate diagnosis of primary 3-oxo-Delta4-steroid 5beta-reductase deficiency[J]. J Gastroenterol Hepatol, 2009, 24(5): 776-785. DOI: 10.1111/j.1440-1746.2008.05669.x. |
| [15] |
CHENG Y, GUO L, DENG M, et al. Clinical feature and genetic analysis of a family affected by congenital bile acid synthesis defect type 2: Identification of 2 novel mutations in AKR1D1 gene[J]. Chin J Contemp Pediatr, 2017, 19(7): 734-740. DOI: 10.7499/j.issn.1008-8830.2017.07.002. |
| [16] |
ZHANG MH, SETCHELL KD, ZHAO J, et al. Δ4-3-oxosteroid-5β-reductase deficiency: Responses to oral bile acid therapy and long-term outcomes[J]. World J Gastroenterol, 2019, 25(7): 859-869. DOI: 10.3748/wjg.v25.i7.859. |
| [17] |
NIKOLAOU N, ARVANITI A, APPANNA N, et al. Glucocorticoids regulate AKR1D1 activity in human liver in vitro and in vivo[J]. J Endocrinol, 2020, 245(2): 207-218. DOI: 10.1530/JOE-19-0473. |
DownLoad: